130 related articles for article (PubMed ID: 28849882)
1. [Cognitive-cytokine effect of nonsteroidal antiinflammatory drugs in the therapy of elderly patients with osteoarthritis].
Zolotovskaia IA; Davydkin IL
Adv Gerontol; 2017; 30(3):381-389. PubMed ID: 28849882
[TBL] [Abstract][Full Text] [Related]
2. Predictors of response to cyclo-oxygenase-2 inhibitors in osteoarthritis: pooled results from two identical trials comparing etoricoxib, celecoxib, and placebo.
Bingham CO; Smugar SS; Wang H; Peloso PM; Gammaitoni A
Pain Med; 2011 Mar; 12(3):352-61. PubMed ID: 21332932
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies.
Bingham CO; Sebba AI; Rubin BR; Ruoff GE; Kremer J; Bird S; Smugar SS; Fitzgerald BJ; O'Brien K; Tershakovec AM
Rheumatology (Oxford); 2007 Mar; 46(3):496-507. PubMed ID: 16936327
[TBL] [Abstract][Full Text] [Related]
4. [Effect of nonsteroidal anti-inflammatory drugs on the indicators of cardiovascular risk in patients with acute nonspecific back pain].
Zolotovskaya IA; Davydkin IL
Ter Arkh; 2015; 87(12):18-25. PubMed ID: 26978413
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of low-dose SoluMatrix meloxicam in the treatment of osteoarthritis pain: a 12-week, phase 3 study.
Altman R; Hochberg M; Gibofsky A; Jaros M; Young C
Curr Med Res Opin; 2015 Dec; 31(12):2331-43. PubMed ID: 26503347
[TBL] [Abstract][Full Text] [Related]
6. The effects of nonsteroidal anti-inflammatory drugs on clinical outcomes, synovial fluid cytokine concentration and signal transduction pathways in knee osteoarthritis. A randomized open label trial.
Gallelli L; Galasso O; Falcone D; Southworth S; Greco M; Ventura V; Romualdi P; Corigliano A; Terracciano R; Savino R; Gulletta E; Gasparini G; De Sarro G
Osteoarthritis Cartilage; 2013 Sep; 21(9):1400-8. PubMed ID: 23973155
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the safety, tolerability, and efficacy of meloxicam tablets in patients with osteoarthritis.
Prouse PJ; Bevis PJ; Bluhmki E; Distel M
Clin Ther; 1996; 18(3):429-39. PubMed ID: 8829018
[TBL] [Abstract][Full Text] [Related]
8. Etoricoxib in the treatment of Korean patients with osteoarthritis in a double-blind, randomized controlled trial.
Yoo MC; Yoo WH; Kang SB; Park YW; Kim SS; Moon KH; Song YW; Min BW; Cho YJ; Moon SH; Bin SI; Baek HJ; Shim SC; Lee SW; Yoo DH; Mehta A; Skuban A; Cukrow DM; Vandormael K; Yan L
Curr Med Res Opin; 2014 Dec; 30(12):2399-408. PubMed ID: 25133963
[TBL] [Abstract][Full Text] [Related]
9. Etoricoxib improves osteoarthritis pain relief, joint function, and quality of life in the extreme elderly.
Huang WN; Tso TK
Bosn J Basic Med Sci; 2018 Feb; 18(1):87-94. PubMed ID: 28954205
[TBL] [Abstract][Full Text] [Related]
10. Dose reduction of meloxicam in dogs with osteoarthritis-associated pain and impaired mobility.
Wernham BG; Trumpatori B; Hash J; Lipsett J; Davidson G; Wackerow P; Thomson A; Lascelles BD
J Vet Intern Med; 2011; 25(6):1298-305. PubMed ID: 22092620
[TBL] [Abstract][Full Text] [Related]
11. [Tolerance to celecoxib and meloxicam in patients with intolerance to nonsteroidal anti-inflammatory drugs].
Vázquez-Cortés S; Vázquez-Fuertes L; Rodríguez-Alvarez M; Reig Rincón de Arellano I; Martínez-Cócera C
An Med Interna; 2008 Apr; 25(4):163-7. PubMed ID: 18604331
[TBL] [Abstract][Full Text] [Related]
12. Characterization of osteoarthritis in cats and meloxicam efficacy using objective chronic pain evaluation tools.
Guillot M; Moreau M; Heit M; Martel-Pelletier J; Pelletier JP; Troncy E
Vet J; 2013 Jun; 196(3):360-7. PubMed ID: 23416029
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of tramadol/acetaminophen tablets (Ultracet) as add-on therapy for osteoarthritis pain in subjects receiving a COX-2 nonsteroidal antiinflammatory drug: a multicenter, randomized, double-blind, placebo-controlled trial.
Emkey R; Rosenthal N; Wu SC; Jordan D; Kamin M;
J Rheumatol; 2004 Jan; 31(1):150-6. PubMed ID: 14705234
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of avocado/soybean unsaponifiables in the treatment of symptomatic osteoarthritis of the knee and hip. A prospective, multicenter, three-month, randomized, double-blind, placebo-controlled trial.
Blotman F; Maheu E; Wulwik A; Caspard H; Lopez A
Rev Rhum Engl Ed; 1997 Dec; 64(12):825-34. PubMed ID: 9476272
[TBL] [Abstract][Full Text] [Related]
15. The efficacy and cost effectiveness of N of 1 studies with diclofenac compared to standard treatment with nonsteroidal antiinflammatory drugs in osteoarthritis.
Pope JE; Prashker M; Anderson J
J Rheumatol; 2004 Jan; 31(1):140-9. PubMed ID: 14705233
[TBL] [Abstract][Full Text] [Related]
16. [Etoricoxib (Arcoxia)].
Leclercq P; Malaise MG
Rev Med Liege; 2004 May; 59(5):345-9. PubMed ID: 15270001
[TBL] [Abstract][Full Text] [Related]
17. Clinical trial design and patient demographics of the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) study program: cardiovascular outcomes with etoricoxib versus diclofenac in patients with osteoarthritis and rheumatoid arthritis.
Cannon CP; Curtis SP; Bolognese JA; Laine L;
Am Heart J; 2006 Aug; 152(2):237-45. PubMed ID: 16875903
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study.
Singh G; Fort JG; Goldstein JL; Levy RA; Hanrahan PS; Bello AE; Andrade-Ortega L; Wallemark C; Agrawal NM; Eisen GM; Stenson WF; Triadafilopoulos G;
Am J Med; 2006 Mar; 119(3):255-66. PubMed ID: 16490472
[TBL] [Abstract][Full Text] [Related]
19. Lower gastrointestinal events in a double-blind trial of the cyclo-oxygenase-2 selective inhibitor etoricoxib and the traditional nonsteroidal anti-inflammatory drug diclofenac.
Laine L; Curtis SP; Langman M; Jensen DM; Cryer B; Kaur A; Cannon CP
Gastroenterology; 2008 Nov; 135(5):1517-25. PubMed ID: 18823986
[TBL] [Abstract][Full Text] [Related]
20. Low-dose meloxicam (Vivlodex) for osteoarthritis pain.
Med Lett Drugs Ther; 2016 Mar; 58(1490):35-6. PubMed ID: 26963155
[No Abstract] [Full Text] [Related]
[Next] [New Search]
